Literature DB >> 6271825

The clinical pharmacology and dynamics of marihuana cigarette smoking.

M Perez-Reyes, S M Owens, S Di Guiseppi.   

Abstract

We have studied the dynamics of marihuana smoking, the plasma concentration of delta 9-tetrahydrocannabinol (THC), and the pharmacologic effects produced by the sequential smoking of two 1% marihuana cigarettes at a 2-hour interval. Three males and three females, experienced marihuana smokers, participated in the study. The results indicate that each subject smoked his or her two cigarettes at a similar rate. The THC plasma concentrations produced by the smoking of the second cigarette were slightly lower than those produced by the first cigarette. The levels of the psychologic "high" caused by the two cigarettes were similar. However, the first cigarette accelerated the heart twice as much as the second cigarette. Between males and females there were marked differences in the rate at which the cigarettes were smoked. In particular, males took more puffs, took them more often, and consumed the cigarettes more rapidly than females. The plasma concentrations of THC, the self-reported psychologic effects, and the heart rate acceleration produced by the smoking of the two cigarettes were identical between the sexes.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6271825     DOI: 10.1002/j.1552-4604.1981.tb02596.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  16 in total

1.  Identification of recent cannabis use: whole-blood and plasma free and glucuronidated cannabinoid pharmacokinetics following controlled smoked cannabis administration.

Authors:  David M Schwope; Erin L Karschner; David A Gorelick; Marilyn A Huestis
Journal:  Clin Chem       Date:  2011-08-11       Impact factor: 8.327

2.  Cannabinoids and metabolites in expectorated oral fluid following controlled smoked cannabis.

Authors:  Garry Milman; David M Schwope; David A Gorelick; Marilyn A Huestis
Journal:  Clin Chim Acta       Date:  2012-01-20       Impact factor: 3.786

3.  Factors affecting variability in the urinary biomarker 1,6-hexamethylene diamine in workers exposed to 1,6-hexamethylene diisocyanate.

Authors:  Linda G T Gaines; Kenneth W Fent; Sheila L Flack; Jennifer M Thomasen; Stephen G Whittaker; Leena A Nylander-French
Journal:  J Environ Monit       Date:  2010-10-26

4.  Effects of acute marijuana smoking in post-menopausal women.

Authors:  R A Benedikt; P Cristofaro; J H Mendelson; N K Mello
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

Review 5.  Human cannabinoid pharmacokinetics.

Authors:  Marilyn A Huestis
Journal:  Chem Biodivers       Date:  2007-08       Impact factor: 2.408

Review 6.  How important are sex differences in cannabinoid action?

Authors:  Liana Fattore; Walter Fratta
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

7.  Medical marijuana laws and suicides by gender and age.

Authors:  D Mark Anderson; Daniel I Rees; Joseph J Sabia
Journal:  Am J Public Health       Date:  2014-01-16       Impact factor: 9.308

8.  Acute marijuana effects on social conversation.

Authors:  S T Higgins; M L Stitzer
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

9.  Characterizing smoking topography of cannabis in heavy users.

Authors:  Erin A McClure; Maxine L Stitzer; Ryan Vandrey
Journal:  Psychopharmacology (Berl)       Date:  2011-09-16       Impact factor: 4.530

10.  Relationships between several pharmacokinetic parameters and psychometric indices of subjective effects of delta 9-tetrahydrocannabinol in man.

Authors:  L L Miller; D M Cocchetto; M Perez-Reyes
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.